• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镁离子与毒蕈碱M2受体变构位点的相互作用。

Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.

作者信息

Burgmer U, Schulz U, Tränkle C, Mohr K

机构信息

Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):363-70. doi: 10.1007/pl00005180.

DOI:10.1007/pl00005180
PMID:9606020
Abstract

Mg2+-ions have been suspected to attenuate the inhibitory effect of allosteric modulators on the dissociation of orthosteric ligands from muscarinic M2 receptors. It was aimed to gain more insight into the molecular events underlying the effect of Mg2+. The interaction of Mg2+ with the allosteric model compounds W84 (hexane-1,6-bis [dimethyl-3'-phthalimidopropylammonium bromide]) and Chin3/6 (hexane-1 ,6-bis[dimethyl-3'-¿4-oxo-2-phenyl-3,4-dihydro-2H-quinazolin-1-yl propylammonium bromide]) was studied in porcine heart muscarinic receptors, the primary binding site of which was occupied by the ligand [3H]N-methylscopolamine ([3H]NMS). The incubation buffer was composed of 4 mM Na2HPO4 and 1 mM KH2PO4 (pH 7.4, 23 degrees C). The retardation of [3H]NMS dissociation (control t1/2=5.6 min) induced by the allosteric test compounds was diminished by 3 mM Mg2+ to a greater extent than to be expected with regard to its contribution to the ionic strength of the buffer solution. Concentration-effect curves for the allosteric retardation of [3H]NMS dissociation by W84 (half maximal effective concentration EC0.5=24 nM in the absence of Mg2+) and by Chin3/6 (EC0.5=28 nM) were shifted by Mg2+ to the right in a parallel fashion. The curve-shift was compatible with a competitive interplay between Mg2+ and the modulators. The pKb-values as a measure of the antagonistic potency of Mg2+, however, differed depending on the modulator, i.e. pKb=3.4 with W84 and pKb=2.8 with Chin3/6. Mg2+ itself was capable of slowing the dissociation of [3H]NMS; the maximal retardation of [3H]NMS dissociation was about 3 fold, the concentration-effect relationship was compatible with a two-site model using the above-mentioned pKb-values as affinity constants. Since the equilibrium-binding of [3H]NMS remained unchanged up to a Mg2+-concentration of 3 mM, the cation appears to inhibit the association and dissociation of [3H]NMS to the same extent in this concentration range. Taken together, the findings indicate that Mg2+ may bind to the allosteric region of muscarinic M2 receptors and that more than one site is involved in this interaction. The sites of action may represent divalent cation binding sites.

摘要

镁离子一直被怀疑会减弱变构调节剂对正构配体从毒蕈碱M2受体解离的抑制作用。目的是更深入地了解镁离子作用背后的分子事件。研究了镁离子与变构模型化合物W84(己烷-1,6-双[二甲基-3'-邻苯二甲酰亚胺基丙基溴化铵])和Chin3/6(己烷-1,6-双[二甲基-3'-(4-氧代-2-苯基-3,4-二氢-2H-喹唑啉-1-基丙基溴化铵])在猪心脏毒蕈碱受体中的相互作用,其主要结合位点被配体[3H]N-甲基东莨菪碱([3H]NMS)占据。孵育缓冲液由4 mM磷酸氢二钠和1 mM磷酸二氢钾组成(pH 7.4,23℃)。变构测试化合物诱导的[3H]NMS解离延迟(对照t1/2 = 5.6分钟)被3 mM镁离子减弱的程度大于根据其对缓冲溶液离子强度的贡献所预期的程度。W84(在无镁离子时半数最大有效浓度EC0.5 = 24 nM)和Chin3/6(EC0.5 = 28 nM)对[3H]NMS解离的变构延迟的浓度-效应曲线被镁离子以平行方式向右移动。曲线移动与镁离子和调节剂之间的竞争性相互作用一致。然而,作为镁离子拮抗效力衡量指标的pKb值因调节剂而异,即与W84时pKb = 3.4,与Chin3/6时pKb = 2.8。镁离子本身能够减缓[3H]NMS的解离;[3H]NMS解离的最大延迟约为3倍,浓度-效应关系与使用上述pKb值作为亲和常数的双位点模型一致。由于在镁离子浓度高达3 mM时[3H]NMS的平衡结合保持不变,在该浓度范围内阳离子似乎对[3H]NMS的结合和解离具有相同程度的抑制作用。综上所述,这些发现表明镁离子可能与毒蕈碱M2受体的变构区域结合,并且这种相互作用涉及多个位点。作用位点可能代表二价阳离子结合位点。

相似文献

1
Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.镁离子与毒蕈碱M2受体变构位点的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):363-70. doi: 10.1007/pl00005180.
2
Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.鉴定毒蕈碱型乙酰胆碱M2受体共同变构位点的[3H]配体。
Mol Pharmacol. 1998 Jul;54(1):139-45. doi: 10.1124/mol.54.1.139.
3
Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.从缓冲液依赖性效价变化推导的与游离型及[3H]N-甲基东莨菪碱占据型毒蕈碱M2受体的变构相互作用模式
Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):512-9. doi: 10.1007/s002100000316.
4
Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.毒蕈碱M2受体阳离子变构调节剂的不同作用模式。
Mol Pharmacol. 1997 Apr;51(4):674-82. doi: 10.1124/mol.51.4.674.
5
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.M2 型乙酰胆碱受体中的变构位点:正构激动剂而非拮抗剂结合后发生重大构象变化的证据。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):267-76. doi: 10.1007/s00210-005-0023-4. Epub 2005 Dec 16.
6
Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.在毒蕈碱型M2受体的共同变构位点上,正构配体和变构配体与[3H]二甲基-W84的相互作用。
Mol Pharmacol. 2003 Jul;64(1):180-90. doi: 10.1124/mol.64.1.180.
7
Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.在系统发育上密切相关的组胺H1受体中测试毒蕈碱受体变构调节剂的特异性。
Naunyn Schmiedebergs Arch Pharmacol. 2000 Feb;361(2):107-12. doi: 10.1007/s002109900176.
8
Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.使用放射性变构剂来测试加拉明与毒蕈碱型乙酰胆碱M(2)受体变构位点结合的协同模型预测。
Mol Pharmacol. 1999 Nov;56(5):962-5. doi: 10.1124/mol.56.5.962.
9
M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.选择性拮抗剂AF-DX 384与M2受体的结合:共同变构位点的可能参与
Mol Pharmacol. 1998 Feb;53(2):304-12. doi: 10.1124/mol.53.2.304.
10
Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.一种有机磷酸酯中毒解毒剂对豚鼠心肌中3H-N-甲基东莨菪碱结合的变构稳定作用。
Pharmacol Toxicol. 1988 Sep;63(3):163-8. doi: 10.1111/j.1600-0773.1988.tb00932.x.

引用本文的文献

1
Mechanism of μ-Opioid Receptor-Magnesium Interaction and Positive Allosteric Modulation.μ-阿片受体-镁相互作用和正变构调节的机制。
Biophys J. 2020 Feb 25;118(4):909-921. doi: 10.1016/j.bpj.2019.10.007. Epub 2019 Oct 14.
2
Ca allostery in PTH-receptor signaling.甲状旁腺激素受体信号转导中的变构调节。
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3294-3299. doi: 10.1073/pnas.1814670116. Epub 2019 Feb 4.
3
Mechanistic insights into allosteric regulation of the A adenosine G protein-coupled receptor by physiological cations.
生理阳离子对 A 腺苷 G 蛋白偶联受体变构调节的机制见解。
Nat Commun. 2018 Apr 10;9(1):1372. doi: 10.1038/s41467-018-03314-9.
4
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor.配体结合集合决定了G蛋白偶联受体上激动剂的分级效力。
J Biol Chem. 2016 Jul 29;291(31):16375-89. doi: 10.1074/jbc.M116.735431. Epub 2016 Jun 13.
5
Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.寡聚 M(2)毒蕈碱型乙酰胆碱受体中单体分子间及单体分子内的变构协同作用。
Biochemistry. 2012 Jun 5;51(22):4518-40. doi: 10.1021/bi3000287. Epub 2012 May 24.
6
Behind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors.幕后揭秘:钙敏感受体变构调节的细胞机制。
Br J Pharmacol. 2012 Mar;165(6):1670-1677. doi: 10.1111/j.1476-5381.2011.01403.x.
7
Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.自身抗体增强慢性恰加斯病中激动剂的作用及与心脏毒蕈碱受体的结合。
J Recept Signal Transduct Res. 2008;28(4):375-401. doi: 10.1080/10799890802262319.
8
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.M2 型乙酰胆碱受体中的变构位点:正构激动剂而非拮抗剂结合后发生重大构象变化的证据。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):267-76. doi: 10.1007/s00210-005-0023-4. Epub 2005 Dec 16.